More about

Basal Cell Carcinoma

News
February 05, 2025
2 min read
Save

Superficial curettage, imiquimod cream 5% sees more failure at 5 years in nodular BCC

Superficial curettage, imiquimod cream 5% sees more failure at 5 years in nodular BCC

Superficial curettage plus imiquimod cream 5% in the treatment of nodular basal cell carcinoma showed more treatment failure at 5 years vs. surgical excision, according to a study.

News
January 13, 2025
1 min read
Save

Last patient completes follow-up for phase 3 study of Ameluz-PDT for basal cell carcinoma

Last patient completes follow-up for phase 3 study of Ameluz-PDT for basal cell carcinoma

A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit, Biofrontera announced in a press release.

News
January 06, 2025
2 min read
Save

Metformin may prevent skin cancer in all skin types

Metformin may prevent skin cancer in all skin types

Metformin may have potential in preventing nonmelanoma skin cancer, including in most populations with skin of color, according to a study.

News
December 20, 2024
2 min read
Save

Dupilumab associated with significantly lower malignancy risks in atopic dermatitis

Dupilumab associated with significantly lower malignancy risks in atopic dermatitis

Patients who used dupilumab for atopic dermatitis had significantly lower risks for internal malignancies than patients using other therapies, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
December 11, 2024
1 min read
Save

FDA clears AIV001 for testing for mixed BCC lesions in facial skin

FDA clears AIV001 for testing for mixed BCC lesions in facial skin

The FDA has cleared AIV001 for testing for the treatment of facial skin with superficial and nodular superficial basal cell carcinoma, according to an AiViva Biopharma press release.

News
August 30, 2024
1 min read
Save

Medicus initiates phase 2 trial of D-MNA for basal cell carcinoma

Medicus initiates phase 2 trial of D-MNA for basal cell carcinoma

The first patient has been enrolled in a phase 2 clinical trial of D-MNA for the treatment of basal cell carcinoma, Medicus Pharma announced in a press release.

News
July 24, 2024
1 min read
Save

New radiation therapy guidelines for nonmelanoma skin cancer stress multidisciplinary care

New radiation therapy guidelines for nonmelanoma skin cancer stress multidisciplinary care

The Dermatology Association of Radiation Therapy has announced new guidelines for the treatment of nonmelanoma skin cancer, according to an association press release.

News
March 22, 2024
1 min read
Save

Jet-injected photodynamic therapy with ALA well tolerated in basal cell carcinoma

Jet-injected photodynamic therapy with ALA well tolerated in basal cell carcinoma

SAN DIEGO — Basal cell carcinoma treatment with jet injection of photodynamic therapy was well tolerated by patients in a pilot study, according to a poster presentation at the American Academy of Dermatology Annual Meeting.

News
January 10, 2024
1 min read
Save

Verrica completes dosing in basal cell carcinoma immunotherapy trial

Verrica completes dosing in basal cell carcinoma immunotherapy trial

The phase 2 clinical trial of Verrica’s peptide-based immunotherapy trial for basal cell carcinoma has enrolled and dosed its final patient, the company announced in a press release.

News
January 04, 2024
1 min read
Save

Top in dermatology: Therapies for basal cell carcinoma, molluscum contagiosum show promise

Top in dermatology: Therapies for basal cell carcinoma, molluscum contagiosum show promise

Early data from a phase 1/2 trial showed promising results for AIV001, AiViva Biopharma’s intradermal basal cell carcinoma treatment, according to a company press release.

View more